MedTrace Logo

A Clinical Trial to Evaluate the Effectiveness of Lactobacillus Reuteri for Periodontitis in a Chinese Population

NCT04129684 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 880

Last updated 2020-05-12

No results posted yet for this study

Summary

The aim of this study is to determine the efficacy of application of Lactobacillus Reuteri probiotics therapy on clinical improvement and on microbial shift in Chinese periodontitis patients.

Conditions

  • Periodontitis

Interventions

OTHER

Probiotics

subgingival delivery and lozenges

Sponsors & Collaborators

  • West China College of Stomatology

    collaborator OTHER

  • Peking University Third Hospital

    collaborator OTHER

  • Hospital of Stomatology, Jilin University

    collaborator UNKNOWN

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-10-01
Completion
2021-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04129684 on ClinicalTrials.gov